| Summary: | Yongxu Jia,* Yaping Gao,* Jing Li,* Zhiwei Chang, Jie Yan, Yanru Qin Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan Province, People’s Republic of China *These authors contributed equally to this work Background and aim: Gastric cancer (GC), a malignant tumor worldwide, is mostly diagnosed at an advanced stage. We selected the oncogene encoding transcription factors MYBL2 to investigate the connection between MYBL2 expression and GC prognosis. Materials and methods: MYBL2 mRNA and protein expression were measured by real-time PCR and immunohistochemistry, respectively. The relationship between MYBL2 protein expression and survival time was estimated by the Kaplan–Meier analysis. Cox proportional hazards model was used to evaluate the prognostic impact of MYBL2 expression. Results: The overexpression of MYBL2 was related to tumor cell differentiation, Lauren type, and metastasis of lymph nodes (P<0.05). In the MYBL2 overexpression group, the median disease free survival was even poorer (P=0.000) and it comes to median overall survival (P=0.000). The study showed that MYBL2 expression was an independent hazard for disease free survival (P=0.004). Conclusion: The results of this study suggest that MYBL2 could indicate a promisingly prognostic biomarker for GC patients. Keywords: MYBL2, gastric cancer, prognosis, upregulation, survival analysis
|
|---|
